Balyasny Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-86,106
| Closed | -$8.35M | – | 1473 |
|
|
2019
Q3 | $8.35M | Buy |
86,106
+18,431
| +27% | +$1.79M | 0.06% | 398 |
|
|
2019
Q2 | $6.93M | Buy |
67,675
+41,635
| +160% | +$4.26M | 0.04% | 433 |
|
|
2019
Q1 | $2.97M | Buy |
+26,040
| New | +$2.97M | 0.02% | 635 |
|
|
2018
Q4 | – | Sell |
-29,581
| Closed | -$1.61M | – | 1711 |
|
|
2018
Q3 | $1.61M | Buy |
29,581
+19,893
| +205% | +$1.09M | 0.01% | 849 |
|
|
2018
Q2 | $802K | Sell |
9,688
-20,736
| -68% | -$1.72M | ﹤0.01% | 1014 |
|
|
2018
Q1 | $2.03M | Sell |
30,424
-27,756
| -48% | -$1.85M | 0.01% | 816 |
|
|
2017
Q4 | $2.99M | Sell |
58,180
-71,703
| -55% | -$3.69M | 0.01% | 826 |
|
|
2017
Q3 | $11.6M | Buy |
129,883
+70,483
| +119% | +$6.28M | 0.05% | 390 |
|
|
2017
Q2 | $3.55M | Buy |
59,400
+30,400
| +105% | +$1.82M | 0.01% | 671 |
|
|
2017
Q1 | $1.55M | Sell |
29,000
-42,600
| -59% | -$2.27M | 0.01% | 816 |
|
|
2016
Q4 | $3.57M | Sell |
71,600
-124,300
| -63% | -$6.2M | 0.02% | 623 |
|
|
2016
Q3 | $11.8M | Buy |
195,900
+98,400
| +101% | +$5.91M | 0.07% | 353 |
|
|
2016
Q2 | $4.99M | Buy |
+97,500
| New | +$4.99M | 0.03% | 417 |
|